A complete selection of highly specific monoclonal antibodies to the nuclear hormone receptor protein family is available. Nuclear hormone receptors are targets for drug development as many are implicated in diabetes and other endocrine disorders, as well as cancer. These molecules are ligand-dependent transcription factors that regulate gene expression in response to a range of developmental, physiological and environmental cues.